Background Reliable biomarkers for assessing the viability of the donor hearts undergoing ex vivo perfusion remain elusive. A unique feature of normothermic ex vivo perfusion on the …
Preclinical disease models are important for the advancement of therapeutics towards human clinical trials. One of the difficult tasks of developing a well-characterized model is …
MM Pla, A Evans, P Lezberg, DE Bowles - Cardiac Gene Therapy …, 2022 - Springer
Recent advances in ex vivo perfusion have enabled an extended preservation time for solid organs prior to transplantation allowing for possible resuscitation of the donor organ during …
MM Pla, Y Chiang, JN Roan… - … -New Insights in …, 2022 - books.google.com
Gene therapy is an advanced treatment approach that alters the genetic composition of cells to confer therapeutic protein or RNA expression to the target organ. It has been successfully …
S Torai, K Kurauchi, E Kobayashi - Transplantation Proceedings, 2023 - Elsevier
Background Second warm ischemia (SWI) injury between the completion of vascular anastomosis and graft reperfusion has been a longstanding issue in organ transplantation …
M Mendiola Pla, CA Milano, Y Chiang… - Journal of …, 2023 - Springer
The porcine intra-abdominal heterotopic heart transplantation model allows for the assessment of immunologic effects on cardiac transplantation without relying on the allograft …